Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 396.00
-19.50 (-4.69%)
Jul 17, 2026, 1:30 PM CST
Bora Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Bora Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $673.55. The average 1-year stock price forecast is 70.09% higher than the current stock price, while the lowest is $430.00 (+8.59%) and the highest is $1,060 (+167.68%).
Price Target: $673.55 (+70.09%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Bora Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Financial Forecast
Revenue This Year
23.07B
from 19.01B
Increased by 21.31%
Revenue Next Year
30.57B
from 23.07B
Increased by 32.55%
EPS This Year
34.22
from 23.24
Increased by 47.24%
EPS Next Year
46.31
from 34.22
Increased by 35.33%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.